Enter now
Enjoy 3 entries for the price of 2 if you qualify for multiple categories!
Innovation & Collaboration of the Year
Summary
Recognising innovative projects established to fuel the advancement of precision medicine.
Who Should Enter
This award is open to companies, teams, or collaborations that have launched innovative projects aimed at advancing precision medicine. Entrants could include pharma and biotech organizations, academic groups, or multi-stakeholder consortia that have demonstrated measurable success in innovation.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Best Industry-Academic Collaboration of the Year
Summary
Recognizing a standout partnership between industry and academia in advancing precision medicine.
Who Should Enter
This category is open to partnerships between industry and academic institutions that have demonstrated exceptional collaboration to advance precision medicine.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Excellence in Patient-Centric Precision Medicine
Summary
For companies placing patients at the heart of their precision medicine strategies.
Who Should Enter
Open to organizations that prioritize patient needs in their precision medicine strategies, demonstrating impactful patient-centric approaches in research, development, or implementation.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Excellence in Rare Disease Precision Medicine
Summary
For outstanding work in developing precision medicine solutions for rare disease
Who Should Enter
This category is open to organizations that have made significant strides in developing precision medicine solutions for rare diseases.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Best Precision Medicine Start-up of the Year
Summary
Recognizing an emerging precision medicine company demonstrating exceptional innovation, impact, and potential for future growth.
Who Should Enter
Start-up companies specializing in precision medicine with impactful achievements or notable advancements in their early years, including innovative solutions, securing funding, or demonstrating commercial viability.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Champion of Tailored Therapies for Oncology
Summary
For a team dedicated to developing oncology therapies tailored to individual needs.
Who Should Enter
Organizations that have demonstrated exceptional work in developing oncology therapies tailored to individual patient needs.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
The Omics Data Visionary Award
Summary
Referencing multi-omics approaches often integral to precision medicine.
Who Should Enter
Open to organizations or teams that have harnessed the power of multi-omics data to advance precision medicine.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
AI Innovation of the Year
Summary
Highlights breakthroughs in AI technologies to optimise precision medicine.
Who Should Enter
This award is open to organizations that have demonstrated groundbreaking use of artificial intelligence in precision medicine.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
CRO Provider of the Year
Summary
Recognizing a Contract Research Organization (CRO) that has demonstrated excellence in supporting precision medicine research
Who Should Enter
Contract Research Organizations (CROs) specializing in precision medicine services, including clinical trial design, biomarker analysis, patient recruitment or regulatory support.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Diagnostic Development Breakthrough of the Year
Summary
Recognizing a groundbreaking advancement in diagnostic tool development that significantly enhances precision medicine applications.
Who Should Enter
This category is open to organizations that have developed innovative diagnostic tools or technologies enabling advancements in precision medicine.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Spatial Insight for Health
Summary
Celebrating innovations that leverage spatial insights to advance therapeutic precision.
Who Should Enter
Open to organizations leveraging spatial biology techniques to generate insights that advance therapeutic precision.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Best Biomarker Development Program of the Year
Summary
For the company demonstrating the most innovative and impactful biomarker development initiative.
Who Should Enter
This category is open to organizations demonstrating excellence in developing biomarkers that enable precision medicine approaches.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Biggest Technology Impact of the Year
Summary
Highlights products and services that use innovative technology that serve the precision medicine industry.
Who Should Enter
Open to organizations delivering innovative technologies that have significantly impacted the precision medicine industry.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Best Journal of the Year
Summary
Recognizing the most impactful and influential journal contributing to the advancement of precision medicine through high-quality research publications.
Who Should Enter
This category is open to journals that have made significant contributions to advancing the understanding and dissemination of precision medicine research.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Patient Advocacy & Partnership Award
Summary
This award celebrates the outstanding efforts of patient advocacy groups that work tirelessly to promote awareness of specific diseases or conditions, empower patients, and amplify the patient voice in research, policy, and healthcare. The award recognizes those who have made a profound impact in advancing the patient-centric approach in healthcare and driving meaningful change for patients and their families.
Who Should Enter?
This award is open to patient advocacy groups or non-profit organizations that are dedicated to championing patient needs, raising awareness, and advancing the rights and needs of those affected by specific diseases or conditions.
Entries should be based on activities undertaken between 1 Jan 2024 – 30 April 2025.
Outstanding Contribution to Precision Medicine
Summary
This award recognizes individuals who have made exceptional, lasting contributions to the advancement of precision medicine. It honours those whose groundbreaking work has driven innovation, fostered collaboration, and shaped the future of personalized healthcare. Whether through pioneering research, transformative technologies, or leadership within the field, this award celebrates those whose efforts have had a profound impact on the precision medicine landscape.
Who Should Enter
This award is open to individuals who have made significant and enduring contributions to the field of precision medicine. It recognizes visionary pioneers or leaders whose work has driven innovation, collaboration, and advancement in the industry.